• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑肿瘤中端粒维持机制的无创评估。

Non-invasive assessment of telomere maintenance mechanisms in brain tumors.

机构信息

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.

Department of Neurological Surgery, Helen Diller Research Center, University of California San Francisco, San Francisco, CA, USA.

出版信息

Nat Commun. 2021 Jan 4;12(1):92. doi: 10.1038/s41467-020-20312-y.

DOI:10.1038/s41467-020-20312-y
PMID:33397920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7782549/
Abstract

Telomere maintenance is a universal hallmark of cancer. Most tumors including low-grade oligodendrogliomas use telomerase reverse transcriptase (TERT) expression for telomere maintenance while astrocytomas use the alternative lengthening of telomeres (ALT) pathway. Although TERT and ALT are hallmarks of tumor proliferation and attractive therapeutic targets, translational methods of imaging TERT and ALT are lacking. Here we show that TERT and ALT are associated with unique H-magnetic resonance spectroscopy (MRS)-detectable metabolic signatures in genetically-engineered and patient-derived glioma models and patient biopsies. Importantly, we have leveraged this information to mechanistically validate hyperpolarized [1-C]-alanine flux to pyruvate as an imaging biomarker of ALT status and hyperpolarized [1-C]-alanine flux to lactate as an imaging biomarker of TERT status in low-grade gliomas. Collectively, we have identified metabolic biomarkers of TERT and ALT status that provide a way of integrating critical oncogenic information into non-invasive imaging modalities that can improve tumor diagnosis and treatment response monitoring.

摘要

端粒维持是癌症的普遍标志。大多数肿瘤,包括低级别少突胶质细胞瘤,使用端粒酶逆转录酶(TERT)表达来维持端粒,而星形细胞瘤则使用端粒的替代性延长(ALT)途径。虽然 TERT 和 ALT 是肿瘤增殖的标志,也是有吸引力的治疗靶点,但缺乏用于成像 TERT 和 ALT 的转化方法。在这里,我们展示了 TERT 和 ALT 与基因工程和患者来源的神经胶质瘤模型以及患者活检中的独特 H-磁共振波谱(MRS)可检测代谢特征相关。重要的是,我们利用这些信息从机制上验证了将[1-C]-丙氨酸到丙酮酸的极化作为 ALT 状态的成像生物标志物,以及将[1-C]-丙氨酸到乳酸的极化作为低级别神经胶质瘤中 TERT 状态的成像生物标志物。总的来说,我们已经确定了 TERT 和 ALT 状态的代谢生物标志物,为将关键致癌信息整合到可以改善肿瘤诊断和治疗反应监测的非侵入性成像方式提供了一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/61c433eff980/41467_2020_20312_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/de6a73b6cb7a/41467_2020_20312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/19586c144c9f/41467_2020_20312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/0cc56da4ace6/41467_2020_20312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/4339ccb98597/41467_2020_20312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/91015f6b182b/41467_2020_20312_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/5714d2fe8aba/41467_2020_20312_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/e563c93af755/41467_2020_20312_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/52ea97587cfd/41467_2020_20312_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/61c433eff980/41467_2020_20312_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/de6a73b6cb7a/41467_2020_20312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/19586c144c9f/41467_2020_20312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/0cc56da4ace6/41467_2020_20312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/4339ccb98597/41467_2020_20312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/91015f6b182b/41467_2020_20312_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/5714d2fe8aba/41467_2020_20312_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/e563c93af755/41467_2020_20312_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/52ea97587cfd/41467_2020_20312_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/7782549/61c433eff980/41467_2020_20312_Fig9_HTML.jpg

相似文献

1
Non-invasive assessment of telomere maintenance mechanisms in brain tumors.脑肿瘤中端粒维持机制的无创评估。
Nat Commun. 2021 Jan 4;12(1):92. doi: 10.1038/s41467-020-20312-y.
2
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.端粒维持的机制及恶性脑胶质瘤相关的治疗弱点。
Neuro Oncol. 2024 Jun 3;26(6):1012-1024. doi: 10.1093/neuonc/noae016.
3
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.端粒维持机制定义高危神经母细胞瘤的临床转归。
Cancer Res. 2020 Jun 15;80(12):2663-2675. doi: 10.1158/0008-5472.CAN-19-3068. Epub 2020 Apr 14.
4
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.端粒的非经典延长是 IDH1 突变星形细胞瘤中端粒维持的主要机制。
J Neurooncol. 2020 Mar;147(1):1-14. doi: 10.1007/s11060-020-03394-y. Epub 2020 Jan 20.
5
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.端粒维持机制在儿童高级别胶质瘤中的预后意义
J Neurooncol. 2014 Mar;117(1):67-76. doi: 10.1007/s11060-014-1374-9. Epub 2014 Jan 30.
6
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.谷氨酸是 IDH1 突变型脑胶质瘤对替莫唑胺治疗反应的非侵入性代谢生物标志物。
Cancer Res. 2020 Nov 15;80(22):5098-5108. doi: 10.1158/0008-5472.CAN-20-1314. Epub 2020 Sep 21.
7
Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer.氘代谢成像报告 TERT 表达与癌症治疗早期反应。
Clin Cancer Res. 2022 Aug 15;28(16):3526-3536. doi: 10.1158/1078-0432.CCR-21-4418.
8
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.端粒酶逆转录酶(TERT)启动子突变和长端粒长度预示着胶质瘤患者的生存率较低且对放疗具有抗性。
Oncotarget. 2016 Feb 23;7(8):8712-25. doi: 10.18632/oncotarget.6007.
9
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.检测恶性神经胶质瘤中端粒延长途径的改变,以改善分子诊断。
J Neurooncol. 2017 Nov;135(2):381-390. doi: 10.1007/s11060-017-2585-7. Epub 2017 Jul 28.
10
The telomere maintenance mechanism spectrum and its dynamics in gliomas.端粒维持机制谱及其在神经胶质瘤中的动态变化。
Genome Med. 2022 Aug 11;14(1):88. doi: 10.1186/s13073-022-01095-x.

引用本文的文献

1
Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma.在胶质母细胞瘤中,从头合成谷胱甘肽和核苷酸生物合成的联合抑制具有合成致死性。
Cell Rep. 2025 May 27;44(5):115596. doi: 10.1016/j.celrep.2025.115596. Epub 2025 Apr 19.
2
Lactylation in Glioblastoma: A Novel Epigenetic Modifier Bridging Epigenetic Plasticity and Metabolic Reprogramming.胶质母细胞瘤中的乳酸化:一种连接表观遗传可塑性和代谢重编程的新型表观遗传修饰因子
Int J Mol Sci. 2025 Apr 4;26(7):3368. doi: 10.3390/ijms26073368.
3
The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases.

本文引用的文献

1
Patient-derived cells from recurrent tumors that model the evolution of -mutant glioma.来自复发性肿瘤的患者源细胞,可模拟突变型胶质瘤的演变。
Neurooncol Adv. 2020 Jul 16;2(1):vdaa088. doi: 10.1093/noajnl/vdaa088. eCollection 2020 Jan-Dec.
2
Hyperpolarized [1-C]pyruvate-to-[1-C]lactate conversion is rate-limited by monocarboxylate transporter-1 in the plasma membrane.在细胞膜中,[1-C]丙酮酸到[1-C]乳酸的转化受单羧酸转运蛋白-1 的限制。
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22378-22389. doi: 10.1073/pnas.2003537117. Epub 2020 Aug 24.
3
Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
胶质细胞端粒体功能障碍在中枢神经系统疾病发病机制中的作用。
Mol Neurobiol. 2024 Aug;61(8):5868-5881. doi: 10.1007/s12035-024-03947-6. Epub 2024 Jan 19.
4
Imaging telomerase reverse transcriptase expression in oligodendrogliomas using hyperpolarized δ-[1-C]-gluconolactone.使用超极化δ-[1-C]-葡萄糖酸内酯成像少突胶质细胞瘤中端粒酶逆转录酶的表达。
Neurooncol Adv. 2023 Jul 21;5(1):vdad092. doi: 10.1093/noajnl/vdad092. eCollection 2023 Jan-Dec.
5
Magnetic resonance spectroscopic correlates of progression free and overall survival in "glioblastoma, IDH-wildtype, WHO grade-4".“胶质母细胞瘤,异柠檬酸脱氢酶野生型,世界卫生组织4级”中无进展生存期和总生存期的磁共振波谱学相关性
Front Neurosci. 2023 Jun 29;17:1149292. doi: 10.3389/fnins.2023.1149292. eCollection 2023.
6
Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer.氘代谢成像报告 TERT 表达与癌症治疗早期反应。
Clin Cancer Res. 2022 Aug 15;28(16):3526-3536. doi: 10.1158/1078-0432.CCR-21-4418.
7
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma.TERT 阳性胶质母细胞瘤中 TERT 或 GABPB1 沉默的影像学生物标志物。
Neuro Oncol. 2022 Nov 2;24(11):1898-1910. doi: 10.1093/neuonc/noac112.
8
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas.氘磁共振波谱成像可用于无创性代谢成像,以评估低级别胶质瘤的肿瘤负荷和对治疗的反应。
Neuro Oncol. 2022 Jul 1;24(7):1101-1112. doi: 10.1093/neuonc/noac022.
9
Detection of alternative lengthening of telomeres mechanism on tumor sections.肿瘤切片中端粒替代延长机制的检测。
Mol Biomed. 2021 Oct 20;2(1):32. doi: 10.1186/s43556-021-00055-y.
10
Nuclear IMPDH Filaments in Human Gliomas.人类神经胶质瘤中的核 IMPDH 丝。
J Neuropathol Exp Neurol. 2021 Oct 26;80(10):944-954. doi: 10.1093/jnen/nlab090.
癌症中端粒维持机制:端粒酶、ALT 或缺乏端粒酶。
Curr Opin Genet Dev. 2020 Feb;60:1-8. doi: 10.1016/j.gde.2020.01.002. Epub 2020 Feb 27.
4
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.分析 2658 个癌症全基因组中的非编码体细胞驱动因子。
Nature. 2020 Feb;578(7793):102-111. doi: 10.1038/s41586-020-1965-x. Epub 2020 Feb 5.
5
Genomic footprints of activated telomere maintenance mechanisms in cancer.癌症中端粒激活维持机制的基因组足迹。
Nat Commun. 2020 Feb 5;11(1):733. doi: 10.1038/s41467-019-13824-9.
6
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.端粒的非经典延长是 IDH1 突变星形细胞瘤中端粒维持的主要机制。
J Neurooncol. 2020 Mar;147(1):1-14. doi: 10.1007/s11060-020-03394-y. Epub 2020 Jan 20.
7
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas.代谢重编程与侵袭性相关,发生在 IDH1mut 低级别胶质瘤的 G-CIMP-high 分子亚型中。
Neuro Oncol. 2020 Apr 15;22(4):480-492. doi: 10.1093/neuonc/noz207.
8
Telomeres and telomerase: three decades of progress.端粒与端粒酶:三十年的进展。
Nat Rev Genet. 2019 May;20(5):299-309. doi: 10.1038/s41576-019-0099-1.
9
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.胱硫醚作为 1p/19q 共缺失型神经胶质瘤的活体磁共振波谱标志物。
Neuro Oncol. 2019 Jun 10;21(6):765-774. doi: 10.1093/neuonc/noz031.
10
Hyperpolarized C MRI: Path to Clinical Translation in Oncology.超极化 C MRI:肿瘤学临床转化之路。
Neoplasia. 2019 Jan;21(1):1-16. doi: 10.1016/j.neo.2018.09.006. Epub 2018 Nov 23.